CT

Photo

Article • Project EU-JUST-CT

CT scans: systematic evaluation of benefits and risks

When is a CT scan justified, i.e. when do the benefits of a CT scan for the patient outweigh possible risks associated with radiation? Justification has been a major issue among radiologists ever since CT has become widely available and widely used. With regard to dose the answer is the well-known ALARA principle: “As low as reasonable achievable“. Now, the European coordinated action on…

Photo

Article • Plenary discussion at ECR 2023

Sustainable radiology: why it takes more than “greener” imaging systems

It’s clear that radiology is lacking in the “green” department: healthcare still causes a large share of global greenhouse gas (GHG) emissions, not least due to diagnostic imaging. Dr Sarah Sheard from Imperial College Healthcare, UK, invited her ECR audience to take a closer look at radiology’s climate footprint – and revealed ways to make the field more sustainable.

Photo

Article • Patient-specific parameters in ionizing radiation usage

A more tailored approach to dose reduction

Radiation exposure in diagnostic and interventional radiology is steadily being reduced, but some important parameters have hardly been taken into account so far, says Dr Kerstin Jungnickel. The medical physics expert explains how patient-specific protocols can improve radiation protection and outlined new findings on the radiosensitivity of certain body regions and their impact.

Photo

Sponsored • Optimization for CT

An update for contrast agent injection

The Accutron CT-D Vision is the next generation of the leading contrast agent injector for computed tomography from Medtron AG. Focusing on the needs of the user, the latest development stage of the Accutron CT-D improves the usability of the CT double-piston contrast agent injector and optimizes its integration into the radiological environment.

Photo

Article • Imaging resource management

Managing the CT contrast media shortage with clinical decision support tools

On March 31st, 2022, a city-wide lockdown to curtail the spread of the Covid-19 virus in Shanghai, China, shuttered the GE Healthcare manufacturing facility that produces 80% of the global supply of iodinated contrast media agents iohexol (Omnipaque) and lodixanol (Visipaque). Although the plant was able to operate at 50% capacity by mid-May, the shutdown resulted in a substantial contrast media…

Photo

Article • Imaging biomarkers, AI support and beyond

New tools for Covid-19 assessment

As knowledge about Covid-19 advances, so does the arsenal of techniques to predict, diagnose and follow up on the disease. At ECR, researchers presented a range of promising imaging modalities to keep track of Covid-19 symptoms, severity, and mortality, often including AI support to enhance or accelerate diagnostics.

515 show more articles
Subscribe to Newsletter